Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01877811
Title CEP-32496 in Patients With Advanced Solid Tumors in Phase 1 and Advanced Melanoma and Metastatic Colorectal Cancer in Phase 2
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Teva Pharmaceutical Industries
Indications

lung squamous cell carcinoma

lung adenocarcinoma

Advanced Solid Tumor

Therapies

RXDX-105

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST